Skip to main content
logo
Whitehawk Therapeutics, Inc. (WHWK)
NASDAQ: WHWK · Real-Time Price · USD
2.210
-0.400 (-15.33%)
At close: Oct 17, 2025, 4:00 PM EDT
2.300
+0.090 (4.07%)
After-hours: Oct 17, 2025, 7:58 PM EDT

Whitehawk Therapeutics Revenue

Whitehawk Therapeutics had revenue of $21.60M in the twelve months ending June 30, 2025, down -9.33% year-over-year. In the year 2024, Whitehawk Therapeutics had annual revenue of $25.98M with 6.69% growth.

Revenue (ttm)
$21.60M
Revenue Growth
-9.33%
P/S Ratio
4.17
Revenue / Employee
$539,900
Employees
40
Market Cap
104.15M

Revenue Chart

Revenue History

Fiscal Year EndRevenueChangeGrowth
Dec 31, 202425.98M1.63M6.69%
Dec 31, 202324.35M9.14M60.06%
Dec 31, 202215.22M14.10M1,258.57%
Dec 31, 20211.12M-13.46M-92.32%
Dec 31, 202014.58M13.83M1,846.60%
Dec 31, 2019 Pro Pro Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company NameRevenue
UnitedHealth Group422.82B
Johnson & Johnson92.15B
Merck & Co.63.62B
AbbVie58.33B
AstraZeneca56.50B
Novartis AG55.19B
Eli Lilly and Company53.26B
Novo Nordisk49.11B
Revenue Rankings

WHWK News

More News